Tarsus Pharmaceuticals, Inc. (TARS) stock
TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/304% above fair value
$75.95−2.25 (-2.88%)
Close on Nov 18, 2026Market cap $3.33BP/E –Yield 0.00%
Tarsus Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Tarsus Pharmaceuticals's market cap was $3.32B on Nov 11, 2026, against $3.39B a year earlier. Over the last 5 years it ranged from $284.88M to $3.48B, with a median of $1.24B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.32B | -4.4% |
| 2025 | Dec 31, 2025 | $3.48B | +64.3% |
| 2024 | Dec 31, 2024 | $2.11B | +215.5% |
| 2023 | Dec 29, 2023 | $670.36M | +71.4% |
| 2022 | Dec 30, 2022 | $391.01M | -15.9% |
| 2021 | Dec 31, 2021 | $465.10M | +289.7% |
| 2020 | Dec 31, 2020 | $119.36M | – |
See a number that looks wrong?